Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOPM.L Regulatory News (OPM)

  • There is currently no data for OPM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IFRS 9 Guidance: No material impact expected

5 Sep 2018 07:00

RNS Number : 7732Z
1PM PLC
05 September 2018
 

 

 

 

5 September 2018

1pm plc

(the "Group" or the "Company")

 

IFRS 9 guidance: no material impact expected upon adoption

1pm plc, the AIM listed alternative finance provider, is pleased to provide guidance on adoption of the accounting standard, IFRS 9 'Financial Instruments' ("IFRS 9" or the "Standard").

The Group is extremely well progressed with both the methodology and accounting that it intends to apply to its lending portfolio under IFRS 9 and is pleased to report, for illustration, that had the Standard applied to the financial year ended 31 May 2018, the estimated impact on the Group's financial results would have been negligible at 0.25% of net assets. The directors believe this reflects the cautious approach to provisioning against receivables already adopted across the Group.

IFRS 9 and IAS 39

IFRS 9 is effective for accounting periods commencing from 1 January 2018 and will replace the existing IAS 39 'Financial Instruments: Recognition and measurement' ("IAS 39").

 

Whilst there are a number of detailed technical differences between IFRS 9 and IAS 39, at a high level, under IFRS 9 impairment provisions will be recognised on the inception of any lending based on the probability of expected default and the typical loss arising on defaults. In effect, IFRS 9 requires the recognition of impairment on client receivables through an expected loss model. This differs from IAS 39 which follows an incurred loss model with specific provisions only being reflected when there is 'objective evidence of impairment'.

 

Potential impact on 1pm

As the Group's financial year end is 31 May, the first year in which adoption of IFRS 9 will be applicable is for the current financial year, which began on 1 June 2018. This adoption will mean that the financial year recently ended on 31 May 2018 will become the prior year comparative. As such, the directors considered it prudent to advance the work on IFRS 9 to ascertain any potential impact on the results for the year ended 31 May 2018.

1pm welcomes the implementation of IFRS 9, since IAS 39 can be challenging to apply, particularly in respect of the lease and loan portfolios where borrowers may be delayed in making, or even miss, a payment for a variety of often understandable and acceptable reasons. It can therefore be far from clear-cut to classify arrears as being an 'objective evidence of impairment', as an occasional delayed or missed payment does not necessarily indicate that recovery of the receivable is at risk. The Group's historical data indicates that receivables with sporadic delayed or missed payments can, and often do, perform well over the full life of the borrowing term.

As a result, under IAS 39, provisioning is assessed on a case by case basis with any expected income and cash shortfall provided for on a specific basis. The Group also currently adopts a cautious policy of maintaining and, where deemed appropriate, increasing an additional provision factoring in historical industry wide-data for potential future loss.

It is this approach to provisioning that enables the directors to be confident that the result of adopting IFRS 9 will be immaterial to the Group's financial results. Furthermore, the detailed work and analysis undertaken confirms that the impact of moving to a position of recognising a likely impairment at the initiation of any lending transaction is materially equal to both the sensible provisioning policy already adopted in the Group's balance sheet and the charge for impairments being incurred in the Group's profit and loss account.

For illustration, as at 31 May 2018, the Group held impairment provisions equal to 1.5% of the entire lending portfolio. The detailed IFRS 9 work indicates that, had IFRS 9 been adopted a provision of 1.6% of the portfolio would have been required, derived from a range of scenarios between 1.3% and 2.8% in the Group's best and worst case scenario and probability modelling.

James Roberts, Chief Financial Officer, commented:

"I am very pleased that on the back of very detailed and thorough work undertaken internally and with the help of appropriate external advisers, the Group is not expected to be materially impacted by the adoption of IFRS 9. This reflects the careful approach to provisioning the Group has already implemented.

It is also worth highlighting that the adoption of the Standard will have no impact either on the Group's ability to declare and pay dividends or on meeting its asset-based lending covenants with wholesale finance providers where there is, and will remain, significant headroom. Additionally, as an accounting adjustment only, the adoption of IFRS 9, will have no impact on revenue recognition, the underlying profitability of the Group's lending, or on cash flows."

 

For further information, please contact:

1pm plc

Ian Smith, Chief Executive Officer

01225 474230

James Roberts, Chief Financial Officer

01225 474230

Cenkos (NOMAD)

Max Hartley (Corporate Finance), Julian Morse (Sales)

0207 397 8900

Walbrook PR

0117 985 8989

Paul Vann

07768 807631

paul.vann@walbrookpr.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUSAARWNAKRUR
Date   Source Headline
7th Dec 20207:00 amRNSChange of Name to Time Finance plc
26th Nov 20207:00 amRNSDirector Share Purchases
9th Nov 20207:08 amRNSHolding(s) in Company
29th Oct 20207:00 amRNSNew Share Option Scheme
28th Oct 20207:00 amRNS1pm receives increased CBILS Lending Allocation
22nd Oct 202010:17 amRNSResult of AGM
22nd Oct 20207:00 amRNSAGM Statement & Notice of Interim Results
8th Oct 20204:13 pmRNSNotice of AGM & Voting Arrangements
8th Oct 20202:00 pmRNSHolding in Company
22nd Sep 20207:00 amRNS2020 Final Results
16th Sep 20207:00 amRNS2020 Final Results: Investor Presentation
23rd Jun 20207:00 amRNSTrading & Funding Update
5th Jun 20207:00 amRNSIssue of Equity & Notice of Results and AGM
18th May 20204:09 pmRNSHolding in Company
7th May 20207:00 amRNSInvitation to Investor Presentation
5th May 20207:00 amRNSCBILS Accreditation & Covid-19 Trading Update
28th Apr 20202:00 pmRNSDirectorate Change
27th Mar 202012:11 pmRNSInterim Dividend Update
26th Mar 20202:15 pmRNSCovid-19 Update
19th Feb 20207:00 amRNSIncreased Funding Facility with NatWest
15th Jan 20207:00 amRNSInterim Results
26th Nov 20197:00 amRNSIncreased and Improved Funding Facilities
8th Nov 20192:57 pmRNSDirector/PDMR Shareholding
8th Nov 201911:34 amRNSHoldings in Company
6th Nov 201911:09 amRNSResult of AGM and GM
21st Oct 20197:00 amRNSNotice of General Meeting
18th Oct 20195:27 pmRNSDirector/PDMR Shareholding
15th Oct 20191:04 pmRNSDirector/PDMR Shareholding
11th Oct 201912:00 pmRNSHoldings in Company
25th Sep 20197:00 amRNS2019 Final Results
3rd Sep 20197:00 amRNSIssue of Equity, Key Dates and Proposed Dividend
17th Jul 201910:00 amRNSHolding(s) in Company
25th Jun 20197:00 amRNSTrading Update
18th Jun 20197:00 amRNSPositive Cashflow achieves earn-out a year early
5th Jun 20197:00 amRNSSenior Management Appointment
20th Mar 20193:29 pmRNSDirector/PDMR Shareholding
14th Mar 20197:00 amRNSSenior Management Appointments
5th Mar 20197:00 amRNSInvoice finance facilities extended with Natwest
13th Feb 20194:57 pmRNSChange in significant shareholding
16th Jan 20194:27 pmRNSDividend Timetable Update
16th Jan 20199:51 amEQSHardman & Co Research: 1pm Plc (OPM): Interim results 1H FY'19: geared up for growth
16th Jan 20197:00 amRNS2019 Interim Results
4th Dec 20187:00 amRNSTrading & Dividend Update; Date of Interim Results
21st Nov 20187:00 amRNSLeasing Life Award
1st Nov 201812:46 pmRNSTotal Voting Rights
25th Oct 20184:05 pmRNSResult of AGM
25th Oct 20187:00 amRNSAGM Statement
22nd Oct 20187:00 amRNSPositive Cashflow achieves First Year earn-out
12th Sep 20189:29 amEQSHardman & Co Research: 1pm (OPM): Group synergies coming through
12th Sep 20187:00 amRNS2018 Final Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.